News & Press Releases

Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.

Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer. 

International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.

Of Counsel Michelle Capezza was quoted by Fiduciary News in an article about the potential repercussions of the Johnson v. Parker-Hannifin case over alleged failures to correctly monitor investments, leading to high-cost share classes. Michelle discusses the case’s implications for professional fiduciaries and 401k plan sponsors.

Toronto Office Manager Partner Mitch Frazer was quoted by Benefits Canada in an article about the Canadian federal government’s decision to transfer $1.9 billion surplus from the Public Service Pension Plan to its general revenue. 

Mintz advised Relation, an industry leader in deploying computation and experimentation to drug discovery, on an equity investment of $15 million from GSK in connection with two simultaneous strategic collaborations with GSK, a global biopharma company. The collaborations are aimed at advancing the development of novel therapeutics for fibrotic diseases and osteoarthritis – conditions which affect millions worldwide and which currently have few treatments addressing their root causes.